Rheumatology
Rheumatology
FOR EACH DISEASE, TRIO DEVELOPS A CUSTOM SOLUTION THAT CAPTURES PATIENT LEVEL DATA THROUGHOUT THE PATIENT JOURNEY, ALL IN REAL-TIME. TRIO’S COVERAGE INCLUDES APPROVED DRUG REGIMENS, PHYSICIANS AND PHARMACIES WITHOUT BIAS.
Data Sources for Rheumatology
Trio has developed a proprietary technology platform that redefines the approach and methodology of collecting retrospective observational data on real world patients.
Aggregate Disparate Data with PHI
Validate Every Patient – Adjudicate Each Data Field
Data Elements
DEMOGRAPHICS /
FAMILY HISTORY
- Patient ID
- Race
- Employment Status
- Occupation
- Pharmacy 1, 2
- Marital Status
- Gender
- Snowbird
- Ethnicity
- FAMILY HISTORY
- Relationship
- Age at Onset
- Age at Death
- Deceased Flag
- Condition
- Cause of Death
LABS
- HbA1c
- ESR (Sedimentation Rate)
- Bilirubin
- CRP
- CBC with Differential
- Complement C3
- eGFR
- Hematocrit
- Platelets
- Complement C4
- HBV viral load
- Uric Acid
- ANA Screen
- HCV viral load
- Lipid Panel
- RF Factor
- TB tests
DISEASE ACTIVITY SCORES
- Rapid 3
- SLEDAI
- BASDAI
- TLAS
- CDAI
- HAQII
- BASMI
- FRAX
- KOOS, JR.
- DAS28
- ASAS
- FIQR
- Grip Strength / Pain Score
- DEXA Scans
- JointExam
- SDAI
- PASI
- Bone Density
CURRENT AND HISTORICAL MED AND DISPENSE INFO
- Full Medication History
- Name
- Start Date
- Stop Date
- NDC Dispense(s)
- Refill Number / Days Supplied
- NDC Product Name(s)
- Shipment Date(s)
- Dispense Item Strength(s)
DIAGNOSTIC INFORMATION
- Diagnostic Code Type
- Diagnostic Code
- Diagnosis Date
INSURANCE INFORMATION
- Insurance Type
- Out of Pocket Amount
- Patient Assistance or
Self Pay - Patient Assistance Amount
- Copay Amount
- Patient Copay
- Type of Provider
- City/State
FUTURE APPOINTMENTS
- Appointment Date
- Resource
ALLERGIES
- Allergen
- Patient ID
- Onset Date
- Reaction
- Date Recorded
- Date Resolved
- Medication Name
- Description
- Type
Patient Tear Sheet
Real Time Aggregated Data is organized and visualized at a patient level for immediate and longitudinal insight.
Click on image below for a 3 page PDF of a Patient Tear Sheet.
Steering Committee
Publication
Journals
- New England Journal of Medicine
- Lancet
- Rheumatology
- Journal of Rheumatology
- Nature
- Clinical Immunology
Associations and
Foundations
- ACR
- EULAR
- PCORI
- Arthritis Foundation
Advisory Board
Affiliations
- Pfizer
- Bristol Myers Squibb
- Gilead
- Janssen
- Novartis
- Roche
- AbbVie
- Eli Lilly
Publications
2022
Reasons For Early Discontinuation Of Targeted Synthetic (ts) Or Biologic (b) DMARDs; Chart Review of 20,343 Drug Episodes Given To Patients With Rheumatoid Arthritis
Kent Kwas Huston, Christopher Adams, Simon Helfgott, Jasvinder Singh, Nehad Soloman, Dan Persons, Scott Milligan, and Colin Edgerton
ACR Convergence 2022: Abstract Number: 0264
Poster Presented at: ACR Convergence
Conference dates: November 10, 2022 - November 14, 2022
Review of 167,990 Same Day RAPID3, CDAI Scores for 61,312 Patients Receiving DMARD Treatment for Rheumatoid Arthritis; Evaluations of Disease Assessments and Treatment Discontinuation
Simon Helfgott, Kent Kwas Huston, Jasvinder Singh, Nehad Soloman, Andrew Frick, Scott Milligan, and Colin Edgerton
ACR Convergence 2022: Abstract Number: 0927
Poster Presented at: ACR Convergence
Conference dates: November 10, 2022 - November 14, 2022
Development of the Patient-Important Outcomes National Data Repository (PIONEER) for Rheumatic Diseases; an Enhanced Database combining Electronic Medical Data with Insight from Chart Reviews
Simon Helfgott, Kent Kwas Huston, Jasvinder Singh, Nehad Soloman, Jeremy Broestl, Kimmi Cox, Kelsey Milligan, and Colin Edgerton
ACR Convergence 2022: Abstract Number: 1954
Poster Presented at: ACR Convergence
Conference dates: November 10, 2022 - November 14, 2022
2021
Management of Gout after Pegloticase; Observations of US Clinical Practice from Trio Health and the American Rheumatology Network (ARN)
Nehad Soloman, Mona Amin, Simon Helfgott, Alexander Hu, Kent Kwas Huston, Jordan Leonard, Kelsey Milligan, Scott Milligan, Jasvinder Singh, John Tesser, and Colin Edgerton
Poster Presented at: International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
Conference dates: May 17, 2021 - May 20, 2021
Management of Gout with Pegloticase; Real-World Utilization and Outcomes from Trio Health and the American Rheumatology Network (ARN)
Nehad Soloman, Mona Amin, Kimmi Cox, Simon Helfgott, Alexander Hu, Kent Kwas Huston, Jordan Leonard, Scott Milligan, Jasvinder Singh, John Tesser, and Colin Edgerton
Poster Presented at: International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
Conference dates: May 17, 2021 - May 20, 2021
Real-World Utilization of Janus Kinase Inhibitors (JAKs) and Biologics in Patients with Rheumatoid Arthritis (RA)
Jasvinder A. Singh, MD, MPH, Janna Radtchenko, MBA, Nehad Soloman, MD, Kwas Huston, MD, Simon M. Helfgott, MD, and Colin C. Edgerton, MD
Poster Presented at: International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
Conference dates: May 17, 2021 - May 20, 2021
Increasing Use of Biologics in Treatment of Systemic Lupus Erythematosus Patients in US Clinical Practice: Real-World Observations from Trio Health and the American Rheumatology Network (ARN)
Simon Helfgott, Deepali Rane, Kent Kwas Huston, Jeremy Broestl, Jasvinder Singh, Nehad Soloman, and Colin Edgerton
Poster Presented at: International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
Conference dates: May 17, 2021 - May 20, 2021
Outcomes with Infliximab and Its Biosimilars in Patients with Rheumatoid Arthritis (RA): Real-World Experience in the US
Simon Helfgott, MD, Janna Radtchenko, MBA, Nehad Soloman, MD, Kent Kwas Huston, MD, Jasvinder Singh, MD, MPH, and Colin Edgerton, MD
Poster Presented at: International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
Conference dates: May 17, 2021 - May 20, 2021
Disparities in Targeted Immune Modulating (TIM) Treatment for Elderly Compared to Younger Patients with Psoriatic Arthritis (PSA)
Jasvinder Singh, Andrew Frick, Simon Helfgott, Kent Kwas Huston, Nehad Soloman, John Tesser, and Colin Edgerton
Poster Presented at: International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
Conference dates: May 17, 2021 - May 20, 2021
Experience with Apremilast in Treatment of Psoriatic Arthritis in US Clinical Practice; Assessments from Trio Health and the American Rheumatology Network (ARN)
Colin Edgerton, Andrew Frick, Simon Helfgott, Ken Kwas Huston, Jasvinder Singh, and Nehad Soloman
Poster Presented at: International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
Conference dates: May 17, 2021 - May 20, 2021
Real-World Utilization of Janus Kinase Inhibitors (JAKs) and Biologics in Patients with Rheumatoid Arthritis (RA)
Janna Radtchenko, Jasvinder A. Singh, MD, MPH, Nehad Soloman, MD, Kwas Huston, MD, Simon M. Helfgott, MD, and Colin C. Edgerton, MD
Poster Presented at: Academy of Managed Care Pharmacy (AMCP)
Conference dates: April 12, 2021 - April 16, 2021
2020
Real-World Utilization of Infliximab (IFX) and Its Biosimilars in Patients (Pts) with Rheumatoid Arthritis (RA) Since the First Biosimilar Approval in the US
Simon Helfgott, Janna Radtchenko, Nehad Soloman, Kent Kwas Huston, Jasvinder Singh, and Colin Edgerton
Arthritis Rheumatol. 2020; 72 (suppl 10)
Poster Presented at: ACR Convergence
Conference dates: November 5, 2020 - November 9, 2020
Increasing Use of Biologics in Treatment of Systemic Lupus Erythematosus Patients in US Clinical Practice: Real-World Observations from Trio Health and the American Rheumatology Network
Simon Helfgott, Jeremy Broestl, Kent Kwas Huston, Deepali Rane, Jasvinder Singh, Nehad Soloman, and Colin Edgerton
Arthritis Rheumatol. 2020; 72 (suppl 10)
Poster Presented at: ACR Convergence
Conference dates: November 5, 2020 - November 9, 2020
Management of Gout After Pegloticase; Observations of US Clinical Practice from Trio Health and the American Rheumatology Network (ARN)
Nehad Soloman, Mona Amin, Simon Helfgott, Alexander Hu, Kent Kwas Huston, Jordan Leonard, Kelsey Milligan, Scott Milligan, Jasvinder Singh, John Tesser, and Colin Edgerton
Arthritis Rheumatol. 2020; 72 (suppl 10)
Poster Presented at: ACR Convergence
Conference dates: November 5, 2020 - November 9, 2020
Management of Gout with Pegloticase; Real-World Utilization and Outcomes from Trio Health and the American Rheumatology Network (ARN)
Nehad Soloman, Mona Amin, Kimmi Cox, Simon Helfgott, Alexander Hu, Kent Kwas Huston, Jordan Leonard, Scott Milligan, Jasvinder Singh, John Tesser, and Colin Edgerton
Arthritis Rheumatol. 2020; 72 (suppl 10)
Poster Presented at: ACR Convergence
Conference dates: November 5, 2020 - November 9, 2020
Experience with Apremilast in Treatment of Psoriatic Arthritis in US Clinical Practice; Assessments from Trio Health and the American Rheumatology Network (ARN)
Colin Edgerton, Andrew Frick, Simon Helfgott, Kent Kwas Huston, Jasvinder Singh, and Nehad Soloman
Arthritis Rheumatol. 2020; 72 (suppl 10)
Poster Presented at: ACR Convergence
Conference dates: November 5, 2020 - November 9, 2020
The “Why” of Drug Discontinuation; Clinical Review of EMR Notes for 2,545 Patients with Rheumatic Diseases
Kent Kwas Huston, Simon Helfgott, Scott Milligan, Jasvinder Singh, Nehad Soloman, Brandon Weil, and Colin Edgerton
Arthritis Rheumatol. 2020; 72 (suppl 10)
Poster Presented at: ACR Convergence
Conference dates: November 5, 2020 - November 9, 2020
Change in Utilization of Outpatient Services at US Community Rheumatology Practices During COVID-19 Outbreak
Kent Kwas Huston, Nehad Soloman, Janna Radtchenko, Simon Helfgott, Jasvinder Singh, and Colin Edgerton
Arthritis Rheumatol. 2020; 72 (suppl 10)
Poster Presented at: ACR Convergence
Conference dates: November 5, 2020 - November 9, 2020
Outpatient Costs in Rheumatoid Arthritis (RA) Patients With VS Without Comorbidities
Colin Edgerton, Janna Radtchenko, and V. Michael Holers
DOI: 10.1016/j.jval.2020.04.691
Poster Presented at: International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
Conference dates: May 18, 2020 - May 22, 2020
2019
Outpatient Costs and Evaluation and Management (E&M) Expenditure Trends in Rheumatoid Arthritis (RA) Patients Treated with Biologic Therapies in US Community Practices
Colin C. Edgerton, Janna Radtchenko, and V. Michael Holers
Arthritis Rheumatol. 2019; 71 (suppl 10): Abstract #1138
Poster Presented at: 2019 ACR/ARP Annual Meeting
Conference dates: November 8, 2019 - November 13, 2019
